Please login to the form below

Not currently logged in
Email:
Password:

Biotie

This page shows the latest Biotie news and features for those working in and with pharma, biotech and healthcare.

Acorda acquires Biotie to expand in Parkinson's disease

Acorda acquires Biotie to expand in Parkinson's disease

Acorda acquires Biotie to expand in Parkinson's disease. Strikes $363m deal for Finnish firm. ... Biotie also has a royalty stream from Lundbeck's sales of Selincro(nalmefene), which was launched in 2013 for the treatment of alcohol dependency.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    410. Biotie Oy/ Acorda. Acquisition company. CNS portfolio includes tozadenant for Parkinson's in p2b .

  • Pharma deals during September 2012 Pharma deals during September 2012

    Lundbeck has subscribed for 4.6 per cent of Biotie Therapeutics shares for 10m (25 per cent premium to the subscription price). ... Biotie will receive additional sales milestones on achievement of undisclosed sales target in Japan, increasing total

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics